Patient preferences for oropharyngeal cancer treatment de-escalation.
about
Is radiation dose reduction the right answer for HPV-positive head and neck cancer?Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Update on De-intensification and Intensification Studies in HPV.Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapyOutcomes measurement in patients with head and neck cancer.Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma.Should We De-escalate the Treatment for HPV-Positive Tumors?The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.Surgically treated oropharyngeal cancer: risk factors and tumor characteristics.Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.Speech-language pathology care and short- and long-term outcomes of oropharyngeal cancer treatment in the elderly.Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapy.Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches
P2860
Q27024764-64FCDEB6-9302-4B9F-99E4-88F431C5AD1CQ33809126-DBFF4E79-77AA-4ECD-9C06-0BA188EA76A0Q34541908-985F3899-9472-4AEA-872A-6CB364F775E9Q35418808-F62AE3A8-E7F2-42F0-9E60-AC94D0ED95CBQ38184459-FA3B873F-3EDF-4B1E-9036-ED140C621DB0Q38195513-3DEFF37A-B58B-4DE0-B3A4-93064D102832Q38267294-F4710218-0145-4EAC-BD35-B437DDD3A5CDQ38815058-AC52671E-0C25-4CCB-9A1F-535A556C35C7Q40966363-9495AAC5-F5AF-4750-8199-A3FDEF53E5D6Q42232492-E43F4EEF-2640-4F83-9F26-2203F0161F2CQ46200171-0A9A9024-BEE1-4524-B867-8F309D343061Q47745836-4F0CD08F-68C7-4B43-BEFA-9132FE9D6327Q48259007-EA375D5B-2121-4085-9A95-977844A5594AQ55246604-5563E556-731D-4B86-AB1B-5D4F77490873Q57816910-16A12A77-9D8B-4C93-A68F-4702E3E7F442
P2860
Patient preferences for oropharyngeal cancer treatment de-escalation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Patient preferences for oropharyngeal cancer treatment de-escalation.
@en
Patient preferences for oropharyngeal cancer treatment de-escalation.
@nl
type
label
Patient preferences for oropharyngeal cancer treatment de-escalation.
@en
Patient preferences for oropharyngeal cancer treatment de-escalation.
@nl
prefLabel
Patient preferences for oropharyngeal cancer treatment de-escalation.
@en
Patient preferences for oropharyngeal cancer treatment de-escalation.
@nl
P2093
P2860
P356
P1433
P1476
Patient preferences for oropharyngeal cancer treatment de-escalation.
@en
P2093
Drew C Brotherston
James R Wright
Judith Balogh
Justin Lee
Martin Leung
P2860
P304
P356
10.1002/HED.22930
P577
2012-03-20T00:00:00Z